Literature DB >> 17259516

Diabetes is not treated as a coronary artery disease risk equivalent.

Baiju R Shah1, Janet E Hux, Peter C Austin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17259516     DOI： 10.2337/dc06-1654

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.

Authors:  Anselm K Gitt; Claus Jünger; Wenefrieda Smolka; Kurt Bestehorn
Journal:  Clin Res Cardiol       Date:  2010-06-03       Impact factor: 5.460

2.  Patient navigators for people with chronic disease: protocol for a systematic review and meta-analysis.

Authors:  Elizabeth Kelly; Noah Ivers; Rami Zawi; Lianne Barnieh; Braden Manns; Diane L Lorenzetti; David Nicholas; Marcello Tonelli; Brenda Hemmelgarn; Richard Lewanczuk; Alun Edwards; Ted Braun; Kerry A McBrien
Journal:  Syst Rev       Date:  2015-03-14

3.  Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey.

Authors:  Kerry A McBrien; Christopher Naugler; Noah Ivers; Robert G Weaver; David Campbell; Laura Desveaux; Brenda R Hemmelgarn; Alun L Edwards; Nathalie Saad; David Nicholas; Braden J Manns
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

Review 4.  Patient navigators for people with chronic disease: A systematic review.

Authors:  Kerry A McBrien; Noah Ivers; Lianne Barnieh; Jacob J Bailey; Diane L Lorenzetti; David Nicholas; Marcello Tonelli; Brenda Hemmelgarn; Richard Lewanczuk; Alun Edwards; Ted Braun; Braden Manns
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

5.  Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.

Authors:  W H Wilson Tang; Yuping Wu; Earl B Britt; Naveed Iqbal; Stanley L Hazen
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.